+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Research Grants Program

National Rosacea Society

The Society awards grants of up to $25,000, or higher in special cases, for research on rosacea. Because the etiology of rosacea is unknown, high priority is given to research in such areas as the pathogenesis, progression, mechanism of action, cell biology and potential genetic factors of this conspicuous and often life-disruptive condition. Studies may also be funded in such areas as epidemiology, predisposition, quality of life and associations with environmental and lifestyle factors. Product development studies (e.g., drug or device testing), which are more appropriately funded by commercial sources, will not be considered.

Grant Application Form

The National Rosacea Society is currently accepting proposals for research grants to be awarded in 2026. Applications should be submitted by July 3, 2026.

AI Based Application Success Predictor

1. Direct focus on rosacea pathogenesis and disease mechanisms (highest predictor)

NRS explicitly states that the highest priority is given to research on:

pathogenesis of rosacea
disease progression
mechanisms of action
cell biology
genetic factors

Projects addressing fundamental causes of rosacea are consistently prioritized.

2. Strong scientific significance and potential to advance understanding of rosacea

The grant program's stated goal is to increase knowledge of the causes and key aspects of rosacea that could lead to improved management, prevention, or cure. Projects that answer important unanswered questions are particularly competitive.

Strong examples include:

immune mechanisms
neurovascular biology
inflammatory pathways
microbiome-related mechanisms
genetic susceptibility

3. Innovative and hypothesis-driven research

Reviewers appear to favor studies that investigate novel mechanisms or emerging concepts rather than purely descriptive work.

Past funded projects have explored:

epigenetic mechanisms
antimicrobial peptides and innate immunity
lipidomic changes
artificial intelligence-based disease assessment tools
systemic comorbidities and disease associations

4. Feasible pilot studies with clear methodology

Because NRS grants are relatively modest in size, successful proposals typically have:

focused aims
realistic budgets
achievable timelines
clear experimental design
measurable outcomes

Pilot studies that can generate preliminary data for larger future funding are especially well aligned with the program.

5. Translational relevance to patient care

While basic science is strongly encouraged, NRS also funds studies involving:

epidemiology
predisposition and risk factors
quality of life
environmental triggers
lifestyle associations

Projects that could eventually improve diagnosis, management, or prevention often have an advantage.

6. Investigator expertise and dermatology research track record

Awarded investigators are commonly affiliated with major academic dermatology departments and research institutions. Competitive applicants generally demonstrate:

expertise in dermatology, immunology, genetics, microbiology, or related fields
prior publications
experience conducting clinical or translational research
access to appropriate research infrastructure

7. Potential to build future rosacea research programs

The NRS research program functions largely as seed funding. Projects that can generate preliminary data leading to larger grants, publications, and sustained rosacea research efforts are especially attractive. The Society has funded more than 70 studies and invested over $1.5–1.7 million in rosacea research since the program began.

Specialties

Dermatology

Eligibility Requirements

high priority is given to research in such areas as the pathogenesis, progression, mechanism of action, cell biology and potential genetic factors of this conspicuous and often life-disruptive condition. Studies may also be funded in such areas as epidemiology, predisposition, quality of life and associations with environmental and lifestyle factors. Product development studies (e.g., drug or device testing), which are more appropriately funded by commercial sources, will not be considered.

Sponsor Details

Sponsor Institute/Organizations: National Rosacea Society

Sponsor Type: Corporate/Non-Profit

Address: 4619 N. Ravenswood Ave., Ste. 103 Chicago, IL 60640

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity